Terms ending in 2044
Every in-force patent on Gilead Sciences, Inc.'s record whose computed term ends in 2044, whoever holds it now. Soonest term end first, then patent number.
| Patent | Title | Holder | Status | Expires | Confidence |
|---|---|---|---|---|---|
| US 12,357,577 | Pharmaceutical Formulations and Uses Thereof In force · High confidence | Gilead Sciences, Inc. | In force | High confidence | |
| US 12,723,057 | Antiviral Compounds and Methods of Making and Using the Same In force · High confidence | Gilead Sciences, Inc. | In force | High confidence | |
| US 12,448,388 | PRMT5 Inhibitors and Uses Thereof In force · Medium confidence | Gilead Sciences, Inc. | In force | Medium confidence | |
| US 12,522,582 | Antiviral Indolinyl Compounds and Uses Thereof In force · High confidence | Gilead Sciences, Inc. | In force | High confidence | |
| US 12,655,172 | Solid Forms of a Nucleoside Analogue and Uses Thereof In force · High confidence | Gilead Sciences, Inc. | In force | High confidence | |
| US 12,448,400 | Kras G12D Modulating Compounds In force · High confidence | Gilead Sciences, Inc. | In force | High confidence | |
| US 12,559,553 | IL-31 Modulators for Treating Fxr-Induced Pruritus In force · High confidence | Gilead Sciences, Inc. | In force | High confidence | |
| US 12,559,546 | METHODS OF IDENTIFYING HIV PATIENTS SENSITIVE TO THERAPY WITH gp120 CD4 BINDING SITE-DIRECTED ANTIBODIES In force · High confidence | Gilead Sciences, Inc. | In force | High confidence |
8 of 8 patents shown. Soonest term end first, then patent number.
Updated Nov 17, 2026 · includes USPTO assignment data published Nov 16, 2026, status data published Nov 17, 2026 and grant & fee data published Nov 17, 2026 (weekly) · how we know
Computed patent terms end on the dates shown. Related patents and pending applications may cover overlapping subject matter.